Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 70518-4352, Hydralazine Hydrochloride, tablet, from REMEDYREPACK INC..

Product NDC
70518-4352
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4352 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
70518-4352-07051843520090 TABLET in 1 BOTTLE, PLASTIC (70518-4352-0)
70518-4352-17051843520130 TABLET in 1 BLISTER PACK (70518-4352-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/51c293c1-70e7-48c7-8af1-a8b74312ed56

Use it

Look up 70518-4352 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4352 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-4352. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.